BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32140910)

  • 1. Clinical exome sequencing in neuromuscular diseases: an experience from Turkey.
    Börklü-Yücel E; Demiriz Ç; Avcı Ş; Vanlı-Yavuz EN; Eraslan S; Oflazer P; Kayserili H
    Neurol Sci; 2020 Aug; 41(8):2157-2164. PubMed ID: 32140910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical exome sequencing in the diagnosis of pediatric neuromuscular disease.
    Herman I; Lopez MA; Marafi D; Pehlivan D; Calame DG; Abid F; Lotze TE
    Muscle Nerve; 2021 Mar; 63(3):304-310. PubMed ID: 33146414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population.
    Fattahi Z; Kalhor Z; Fadaee M; Vazehan R; Parsimehr E; Abolhassani A; Beheshtian M; Zamani G; Nafissi S; Nilipour Y; Akbari MR; Kahrizi K; Kariminejad A; Najmabadi H
    Clin Genet; 2017 Mar; 91(3):386-402. PubMed ID: 27234031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service.
    Westra D; Schouten MI; Stunnenberg BC; Kusters B; Saris CGJ; Erasmus CE; van Engelen BG; Bulk S; Verschuuren-Bemelmans CC; Gerkes EH; de Geus C; van der Zwaag PA; Chan S; Chung B; Barge-Schaapveld DQCM; Kriek M; Sznajer Y; van Spaendonck-Zwarts K; van der Kooi AJ; Krause A; Schönewolf-Greulich B; de Die-Smulders C; Sallevelt SCEH; Krapels IPC; Rasmussen M; Maystadt I; Kievit AJA; Witting N; Pennings M; Meijer R; Gillissen C; Kamsteeg EJ; Voermans NC
    J Neuromuscul Dis; 2019; 6(2):241-258. PubMed ID: 31127727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Next-Generation Sequencing in a Large Cohort of Genetically Undiagnosed Patients with Neuromuscular Disorders in Spain.
    Gonzalez-Quereda L; Rodriguez MJ; Diaz-Manera J; Alonso-Perez J; Gallardo E; Nascimento A; Ortez C; Natera-de Benito D; Olive M; Gonzalez-Mera L; Munain AL; Zulaica M; Poza JJ; Jerico I; Torne L; Riera P; Milisenda J; Sanchez A; Garrabou G; Llano I; Madruga-Garrido M; Gallano P
    Genes (Basel); 2020 May; 11(5):. PubMed ID: 32403337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of comprehensive targeted multigene panel sequencing for neuromuscular disorders in Korean patients.
    Park J; Oh HM; Park HJ; Cho AR; Lee DW; Jang JH; Jang DH
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00947. PubMed ID: 31475473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of exome sequencing for the diagnosis of pediatric-onset neuromuscular diseases beyond diagnostic yield: a narrative review.
    Piñeros-Fernández MC; Morte B; García-Giménez JL
    Neurol Sci; 2024 Apr; 45(4):1455-1464. PubMed ID: 37989827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next generation sequencing and its application in the diagnostics of neuromuscular diseases.
    Zídková J; Haberlová J; Kramářová T; Fajkusová L
    Cesk Patol; 2021; 57(3):150-153. PubMed ID: 34551563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
    Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
    Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome and RNA sequencing boost neuromuscular diagnoses to 62% from 34% with exome sequencing alone.
    Marchant RG; Bryen SJ; Bahlo M; Cairns A; Chao KR; Corbett A; Davis MR; Ganesh VS; Ghaoui R; Jones KJ; Kornberg AJ; Lek M; Liang C; MacArthur DG; Oates EC; O'Donnell-Luria A; O'Grady GL; Osei-Owusu IA; Rafehi H; Reddel SW; Roxburgh RH; Ryan MM; Sandaradura SA; Scott LW; Valkanas E; Weisburd B; Young H; Evesson FJ; Waddell LB; Cooper ST
    Ann Clin Transl Neurol; 2024 May; 11(5):1250-1266. PubMed ID: 38544359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Utility of Whole Exome Sequencing in the Neuromuscular Clinic.
    Waldrop MA; Pastore M; Schrader R; Sites E; Bartholomew D; Tsao CY; Flanigan KM
    Neuropediatrics; 2019 Apr; 50(2):96-102. PubMed ID: 30665247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype-guided diagnostic reassessment after exome sequencing in neuromuscular disorders: experiences with a two-step approach.
    Krenn M; Tomschik M; Rath J; Cetin H; Grisold A; Zulehner G; Milenkovic I; Stogmann E; Zimprich A; Strom TM; Meitinger T; Wagner M; Zimprich F
    Eur J Neurol; 2020 Jan; 27(1):51-61. PubMed ID: 31407473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular disorders: finding the missing genetic diagnoses.
    Koczwara KE; Lake NJ; DeSimone AM; Lek M
    Trends Genet; 2022 Sep; 38(9):956-971. PubMed ID: 35908999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diversity of hereditary neuromuscular diseases: Experiences from molecular diagnosis.
    Hsueh HW; Weng WC; Fan PC; Chien YH; Yang FJ; Lee WT; Lin RJ; Hwu WL; Yang CC; Lee NC
    J Formos Med Assoc; 2022 Dec; 121(12):2574-2583. PubMed ID: 35821219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield.
    Ankala A; da Silva C; Gualandi F; Ferlini A; Bean LJ; Collins C; Tanner AK; Hegde MR
    Ann Neurol; 2015 Feb; 77(2):206-14. PubMed ID: 25380242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth.
    Todd EJ; Yau KS; Ong R; Slee J; McGillivray G; Barnett CP; Haliloglu G; Talim B; Akcoren Z; Kariminejad A; Cairns A; Clarke NF; Freckmann ML; Romero NB; Williams D; Sewry CA; Colley A; Ryan MM; Kiraly-Borri C; Sivadorai P; Allcock RJ; Beeson D; Maxwell S; Davis MR; Laing NG; Ravenscroft G
    Orphanet J Rare Dis; 2015 Nov; 10():148. PubMed ID: 26578207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rapid evolution of molecular genetic diagnostics in neuromuscular diseases.
    Volk AE; Kubisch C
    Curr Opin Neurol; 2017 Oct; 30(5):523-528. PubMed ID: 28665809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing and comprehensive data reassessment in 263 adult patients with neuromuscular disorders: insights into the gray zone of molecular diagnoses.
    Krenn M; Wagner M; Zulehner G; Weng R; Jäger F; Keritam O; Sener M; Brücke C; Milenkovic I; Langer A; Buchinger D; Habersam R; Mayerhanser K; Brugger M; Brunet T; Jacob M; Graf E; Berutti R; Cetin H; Hoefele J; Winkelmann J; Zimprich F; Rath J
    J Neurol; 2024 Apr; 271(4):1937-1946. PubMed ID: 38127101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to genetic diagnosis in neuromuscular conditions in the era of next generation sequencing.
    Teoh HL; Sampaio H; Roscioli T; Farrar M
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1384-1385. PubMed ID: 27301348
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted sequencing with expanded gene profile enables high diagnostic yield in non-5q-spinal muscular atrophies.
    Karakaya M; Storbeck M; Strathmann EA; Delle Vedove A; Hölker I; Altmueller J; Naghiyeva L; Schmitz-Steinkrüger L; Vezyroglou K; Motameny S; Alawbathani S; Thiele H; Polat AI; Okur D; Boostani R; Karimiani EG; Wunderlich G; Ardicli D; Topaloglu H; Kirschner J; Schrank B; Maroofian R; Magnusson O; Yis U; Nürnberg P; Heller R; Wirth B
    Hum Mutat; 2018 Sep; 39(9):1284-1298. PubMed ID: 29858556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.